Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hepatitis D

• Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis
• A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection
• Phase IIa Clinical Trial of Hepalatide in CHD Patients
• Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function
• A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function
• A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection
• SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection
• The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With Tenofovir Disoproxil Fumarate
• Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection
• Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
• A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection
• The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection
• A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
• Study to Assess Efficacy and Safety of Bulevirtide in Patients With CHD
• Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)
• Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
• Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon
• A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
• A Study of Lonafarnib With or Without Ritonavir in Patients With HDV
• A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
• A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
• A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
• Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection
• Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
• Titrating-Dose of Lonafarnib in Combination With Ritonavir
• Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
• Lonafarnib With Ritonavir in HDV (LOWR-2)
• Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
• Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
• REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection
• Lonafarnib for Chronic Hepatitis D
• Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
• A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
• HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis
• Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
• Pegylated Interferon to Treat Chronic Hepatitis D
• Lamivudine for Chronic Hepatitis B